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Abstract
Phenotyping electronic health records (EHR) focuses on defining meaningful patient groups
(e.g., heart failure group and diabetes group) and identifying the temporal evolution of patients
in those groups. Tensor factorization has been an effective tool for phenotyping. Most of the
existing works assume either a static patient representation with aggregate data or only model
temporal data. However, real EHR data contain both temporal (e.g., longitudinal clinical visits)
and static information (e.g., patient demographics), which are difficult to model simultaneously.
In this paper, we propose Temporal And Static TEnsor factorization (TASTE) that jointly
models both static and temporal information to extract phenotypes. TASTE combines the
PARAFAC2 model with non-negative matrix factorization to model a temporal and a static
tensor. To fit the proposed model, we transform the original problem into simpler ones which
are optimally solved in an alternating fashion. For each of the sub-problems, our proposed
mathematical re-formulations lead to efficient sub-problem solvers. Comprehensive experiments
on large EHR data from a heart failure (HF) study confirmed that TASTE is up to 14× faster
than several baselines and the resulting phenotypes were confirmed to be clinically meaningful
by a cardiologist. Using 80 phenotypes extracted by TASTE, a simple logistic regression can
achieve the same level of area under the curve (AUC) for HF prediction compared to a deep
learning model using recurrent neural networks (RNN) with 345 features.
1 Introduction
Phenotyping is about identifying patient groups sharing similar clinically-meaningful characteristics
and is essential for treatment development and management [1]. However, the complexity and
heterogeneity of the underlying patient information render a manual phenotyping impractical
for large populations or complex conditions. Unsupervised EHR-based phenotyping based on
tensor factorization, e.g., [2, 3, 4], provides effective alternatives. However, existing unsupervised
phenotyping methods are unable to handle both static and dynamically-evolving information, which
is the focus of this work.
Traditional tensor factorization models [5, 6, 7] assume the same dimensionality along with each
tensor mode. However, in practice one mode such as time can be irregular, e.g., different patients
may vary by the number of clinical visits over time. To handle such longitudinal datasets, [8] and
[9] propose algorithms fitting the PARAFAC2 model [10] which are faster and more scalable for
handling irregular and sparse data. However, these PARAFAC2 approaches only focus on modeling
the dynamically-evolving features for every patient (e.g., the structured codes recorded for every
visit). Static features (such as race and gender) which do not evolve are completely neglected; yet,
they are among important information in phenotyping analyses (e.g., some diseases have the higher
prevalence in a certain race).
To address this problem, we propose a scalable method called TASTE which is able to jointly
model both temporal and static features by combining the PARAFAC2 model with non-negative
matrix factorization as shown in Figure 1. We reformulate the original non-convex problem into
simpler sub-problems (i.e., orthogonal Procrustes, least square and non-negativity constrained least
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Figure 1: TASTE applied on dynamically-evolving structured EHR data and static patient information.
Each Xk represents the medical features recorded for different clinical visits for patient k. Matrix
A includes the static information (e.g., race, gender) of patients. TASTE decomposes {Xk} into
three parts: {Uk}, {Sk}, and V . Static matrix A is decomposed into two parts: {Sk} and F .
Note that {Sk} (personalized phenotype scores) is shared between static and dynamically-evolving
features.
square) and solve each of them efficiently by avoiding unnecessary computations (e.g., expensive
Khatri-Rao products).
We summarize our contributions below:
• Temporal and Static Tensor Factorization: We formulate a new technique which jointly
models static and dynamic features from EHR data as nonnegative factor matrices.
• Fast and Accurate Algorithm: Our proposed fitting algorithm is up to 14 × faster than
the state of the art baseline. At the same time, TASTE preserves model constraints which
promote model uniqueness better than baselines while maintaining interpretability.
• Case Study on Heart Failure Phenotyping: We demonstrate the practical impact
of TASTE through a case study on heart failure (HF) phenotyping. We identified clinically-
meaningful phenotypes confirmed by a cardiologist. Using phenotypes extracted by TASTE,
simple logistic regression can achieve comparable predictive accuracy with deep learning
techniques such as RNNs.
2 Background & Related Work
Table 1 summarizes the notations used in this paper.
Table 1: Notations
Symbol Definition
* Element-wise Multiplication
 Khatri Rao Product
Y ,y matrix, vector
Y (i, :) the i-th row of Y
Y (:, r) the r-th column of Y
Y (i, r) element (i,r) of Y
Xk Feature matrix of patient k
diag(Y ) Extract the diagonal of matrix Y
vec(Y ) Vectorizing matrix Y
svd(Y ) Singular value decomposition on Y
|| · ||2F Frobenius Norm
max(0,Y ) max operator replaces negative values in Y with 0
Y ≥ 0 All elements in Y are non-negative
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2.1 PARAFAC2 Model
The PARAFAC2 model [11], has the following objective function:
minimize
{Uk},{Sk},V
K∑
k=1
1
2
||Xk −UkSkV T ||2F
subject to Uk = QkH, QTkQk = I,
(1)
where Xk ∈ RIk×J is the input matrix, factor matrix Uk ∈ RIk×R, diagonal matrix Sk ∈ RR×R , and
factor matrix V ∈ RJ×R are output matrices. Factor matrix Qk ∈ RIk×R is an orthogonal matrix,
and H ∈ RR×R where Uk = QkH. SPARTan [8] is a method to fit this model for sparse datasets,
as well as COPA [9] incorporates different constraints such as temporal smoothness and sparsity to
the model factors to produce more meaningful results.
Uniqueness property ensures that a decomposition is pursuing the true latent factors, rather than
an arbitrary rotation of them. The unconstrained version of PARAFAC2 in (1) (without constraints
Uk=Qk H and QTk Qk=I ) is not unique. Assume B as an invertible R×R matrix and {Zk} as
R×R diagonal matrices. Then, we can transform UkSkV T as:
UkSkV
T = (UkSkB
−1Z−1k )︸ ︷︷ ︸
Gk
Zk (BV
T )︸ ︷︷ ︸
ET
which is another valid solution achieving the same approximation error [11] - this is problematic
in terms of the interpretability of the result. To promote uniqueness, Harshman [10] introduced
the cross-product invariance constraint, which dictates that UTk Uk should be constant ∀k ∈
{1, . . . ,K}. To achieve that, the following constraint is added: Uk = QkH where QTkQk = I, so
that: UTk Uk = H
TQTkQkH = H
TH = Φ.
2.2 Unsupervised Computational Phenotyping
A wide range of approaches applies tensor factorization techniques to extract phenotypes. [12, 2,
13, 3, 14, 15, 16] incorporate various constraints (e.g., sparsity, non-negativity, integer) into regular
tensor factorization to produce more clinically-meaningful phenotypes. [8, 9] identify phenotypes and
their temporal trends by using irregular tensor factorization based on PARAFAC2 [10]; yet, those
approaches cannot model both dynamic and static features for meaningful phenotype extraction. As
part of our experimental evaluation, we demonstrate that naively adjusting such PARAFAC2-based
approaches to incorporate static information results in biased and less interpretable phenotypes.
The authors of [4] proposed a collective non-negative tensor factorization for phenotyping purposes.
However, the method is not able to jointly incorporate static information such as demographics
with temporal features. Also they do not employ the orthogonality constraint on the temporal
dimension, a strategy known to produce non-unique solutions [10, 11].
3 The TASTE framework
3.1 Intuition
We will explain the intuition of TASTE in the context of phenotyping application.
Input data include both temporal and static features for all K patients:
• Temporal features (Xk); For patient k, we record the medical features for different clinical
visits in matrixXk ∈ RIk×J where Ik is the number of clinical visits and J is the total number
of medical features. Note that Ik can be different for different patients.
• Static features (A): The static features like gender, race, body mass index (BMI), smoking
status 1 are recorded in A ∈ RK×P where K is the total number of patients and P is the
number of static features. In particular, A(k, :) is the static features for kth patient.
1Although BMI and smoking status can change over time, in our data set these values for each patient are constant
over time.
3
Phenotyping process maps input data into a set of phenotypes, which involves the definition of
phenotypes and temporal evolution. Figure 1 illustrates the following model interpretation. First,
phenotype definitions are shared by factor matrices V and F for temporal and static features,
respectively. In particular, V (:, r) or F (:, r) are the rth column of factor matrix V or F which
indicates the participation of temporal or static features in the rth phenotype. Second, personalized
phenotype scores for patient k are provided in the diagonal matrix Sk where its diagonal element
Sk(r, r) indicates the overall importance of the rth phenotype for patient k. Finally, temporal
phenotype evolution for patient k is specified in factor matrix Uk where its rth column Uk(:, r)
indicates the temporal evolution of phenotype r over all clinical visits of patient k.
3.2 Objective function and challenges
We introduce the following objective:
minimize
{Uk},{Qk},
H,{Sk},V ,F
K∑
k=1
(1
2
||Xk −UkSkV T ||2F︸ ︷︷ ︸
PARAFAC2 (1)
)
+
λ
2
||A−WFT ||2F︸ ︷︷ ︸
Coupled Matrix (2)
+
K∑
k=1
(µk
2
||Uk −QkH||2F︸ ︷︷ ︸
Uniqueness (3)
)
subject to QTkQk = I, Uk ≥ 0, Sk ≥ 0, for all k=1,...,K
W (k, :) = diag(Sk) for all k=1,...,K
V ≥ 0, F ≥ 0
(2)
Objective function has three main parts as follows:
1. The first part is related to fitting a PARAFAC2 model that factorizes a set of temporal feature
matrices Xk ∈ RIk×J into Uk ∈ RIk×R, diagonal matrix Sk ∈ RR×R, and V ∈ RJ×R.
2. The second part is for optimizing the static feature matrix A where A ∈ RK×P , W ∈ RK×R and
F ∈ RP×R. λ also is the weight parameter. Common factor matrices {Sk} are shared between
static and temporal features by setting W (k, :)=diag(Sk).
3. The third part enforces both non-negativity of the Uk factor and also minimizes its difference to
QkH . Due to the constraint QTkQk = I, minimizing ||Uk −QkH||2F is encouraging that UTk Uk
is constant over K subjects, which is a desirable property from PARAFAC2 that promotes
uniqueness, and thus enhancing interpretability [11].
4. λ and µk are weighting parameters which all set by user. For simplicity, we set µ1 = µ2 = · · · =
µK = µ.
The challenge in solving the above optimization problem lies in: 1) addressing all the non-negative
constraints especially on Uk, 2) trying to make UTk Uk constant over K subjects by making non-
negative Uk as close as possible to QkH while QkH can contain negative values, and 3) estimating
all factor matrices in order to best approximate both temporal and static input matrices.
3.3 Algorithm
To optimize the objective function (2), we need to update {Qk},H, {Uk},V , {Sk}, and F iteratively.
Although the original problem in Equation 2 is non-convex, our algorithm utilizes the Block
Coordinate Descent framework [17] to mathematically reformulate the objective function (2) into
simpler sub-problems. In each iteration, we update {Qk} based on Orthogonal Procrustes problem
[18] which ensures an orthogonal solution for each Qk. Factor matrix H can be solved efficiently
by least square solvers. For factor matrices {Uk},V , {Sk},F we reformulate objective function (2)
so that the factor matrices are instances of the non-negativity constrained least squares (NNLS)
problem. Each NNLS sub-problem is a convex problem and the optimal solution can be found easily.
We use block principal pivoting method [19] to solve each NNLS sub-problem. The block principal
pivoting method achieved state-of-the-art performance on NNLS problems compared to other
optimization techniques [19]. We provide the details about NNLS problems in the supplementary
material section. We also exploit structure in the underlying computations (e.g., involving Khatri-
Rao products) so that each one of the sub-problems is solved efficiently. Next, we summarize the
solution for each factor matrix.
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3.3.1 Solution for factor matrix Qk
We can reformulate objective function 2 with respect to Qk as follows :
minimize
Qk
µk
∥∥∥UkHT −Qk∥∥∥2
F
subject to QTkQk = I
(3)
More mathematical details about converting Equation 2 to 3 are provided in supplementary
material section. The optimal value of Qk can be computed via Orthogonal Procrustes problem
[18] which has the closed form solution Qk = BkCTk where Bk ∈ RIk×R and Ck ∈ RR×R are the
right and left singular vectors of µkUkHT . Note that each Qk can contain negative values.
3.3.2 Solution for factor matrix H
The objective function with respect to H can be rewritten as:
minimize
H
K∑
k=1
µk
2
∥∥∥QTkUk −H∥∥∥2
F
(4)
without any constraint. The details about updating factor matrix H are provided in supplementary
material section. The value of H that minimizes Equation 4 also minimizes Equation 2. The
update rule for factor matrix H has the following form:
H =
∑K
k=1 µkQ
T
kUk∑K
k=1 µk
.
3.3.3 Solution for phenotype evolution matrix Uk
After updating the factor matrices Qk, H, we focus on solving for Uk. In classic PARAFAC2 [10,
11], this factor is retrieved through the simple multiplication Uk = QkH. However, due to
interpretability concern, we prefer temporal factor matrix Uk to be non-negative because the
temporal phenotype evolution for patient k (Uk) should never be negative. As shown in the next
section, a naive enforcement of non-negativity (max(0,Qk H)) violates the important uniqueness
property of PARAFAC2 (the model constraints). Therefore, we consider Uk as an additional factor
matrix, constrain it to be non-negative and minimize its difference to QkH.
The objective function with respect to Uk can be combined into the following NNLS form:
minimize
Uk
1
2
∥∥∥∥[V Sk√µkI
]
UTk −
[
XTk√
µkH
TQTk
]∥∥∥∥2
F
subject to Uk ≥ 0
(5)
As we mentioned earlier, we update factor matrix Uk based on block principal pivoting method.
3.3.4 Solution for temporal phenotype definition V
Factor matrix V defines the participation of temporal features in different phenotypes. By
considering Equation 2, factor matrix V participates in the PARAFAC2 part with non-negativity
constraint. Therefore, the objective function for factor matrix V have the following form:
minimize
V
1
2
∥∥∥∥∥∥∥∥

U1S1
U2S2
.
UKSK
V T −

X1
X2
.
XK

∥∥∥∥∥∥∥∥
2
F
subject to V ≥ 0
(6)
In order to update V based on block principal pivoting, we need to calculate (UkSk)T (UkSk)
and UkSkXk for all K samples which can be calculated in parallel.
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3.3.5 Solution for factor matrix W or {Sk}
The objective function with respect to W yields the following format:
minimize
Sk
K∑
k=1
(1
2
||Xk −UkSkV T ||2F
)
+
λ
2
||A−WF T ||2F
subject to Sk ≥ 0
W (k, :) = diag(Sk) for all k=1,...,K
(7)
As we mentioned earlier, factor matrices {Sk} is shared between PARAFAC2 input and matrix
A where W (k, :)=diag(Sk). By knowing vec(UkSkV T ) = (V Uk)W (k, :)T , Equation 7 can be
rewritten as:
minimize
Sk
1
2
∥∥∥∥[V Uk√λF
]
W (k, :)T −
[
vec(Xk)√
λA(k, :)T
]∥∥∥∥2
F
subject to W (k, :) ≥ 0
(8)
where  denotes Khatri-Rao product. We can solve the rows of factor matrix W (W (k, :) or
diag(Sk)) separately and in parallel. To update each factor matrix Sk we need to compute two
time-consuming operations: 1)(V Uk)T (V Uk) and 2)(V Uk)Tvec(Xk). The first operation
can be replaced with V TV ∗UTk Uk where * denotes element-wise(hadamard) product [20]. The
second operation also can be replaced with diag(UkXkV T ) [20]. Therefore, the time-consuming
Khatri-Rao Product doesn’t need to be explicitly formed. Each row of W can be efficiently updated
via block principal pivoting.
3.3.6 Solution for static phenotype definition F
Finally, factor matrix F represents the participation of static features for the phenotypes. The
objective function for factor matrix F have the following form:
minimize
F
λ
2
∥∥∥WF T −A∥∥∥2
F
subject to F ≥ 0
(9)
which can be easily updated via block principal pivoting.
3.4 Phenotype inference on new data
Given phenotype definition (V ,F ) and factor matrix H for some training set, TASTE can project
data of new unseen patients into the existing low-rank space. This is useful because healthcare
provider may want to fix the phenotype definition while score new patients with those existing
definitions. Moreover, such a methodology enables using the low-rank representation of patients
such as (Sk) as feature vectors for a predictive modeling task.
Suppose, {X1,X2, ...,XN ′} represents the temporal information of unseen patients {1, 2, ..., N
′}
and A
′ ∈ RN ′×P indicated their static information. TASTE is able to project the new patient’s
information into the existing low-rank space (H , V , and F ) by optimizing {Qn}, {Un} and {Sn}
for the following objective function:
minimize
{Qn},{Un},
{Sn}
N′∑
n=1
(1
2
||Xn −UnSnV T ||2F
)
+
λ
2
||A′ −WFT ||2F
+
N′∑
n=1
(µn
2
||Un −QnH||2F
)
subject to QTnQn = I, for all n = 1, ..., N
′
Un ≥ 0, Sn ≥ 0 for all n = 1, ..., N ′
(10)
Updating factor matrices {Qn} is based on Equation 3. {Un} can be minimized based on
Equation 5. Finally, W can be updated based on Equation 8 where diag(Sn) = W (n, :). Factor
matrix W represents the personalized phenotype scores of all patients.
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4 Experimental Results
We focus on answering the following:
Q1. Does TASTE preserve accuracy and the uniqueness-promoting constraint, while being fast to
compute?
Q2. How does TASTE scale for increasing number of patients (K)?
Q3. Does the static information added in TASTE improve predictive performance for detecting
heart failure?
Q4. Are the heart failure phenotypes produced by TASTE meaningful to an expert cardiologist?
4.1 Data Set Description
Table 2 summarizes the statistics of data sets.
Table 2: Summary statistics of two real data sets.
Dataset # Patients # Temporal Features Mean(Ik) # Static Features
Sutter 59,480 1164 29 22
CMS 151,349 284 50 30
Sutter: The data set contains the EHRs for patients with new onset of heart failure and
matched controls (matched by encounter time, and age). It includes 5912 cases and 59300 controls.
For all patients, encounter features (e.g., medication orders, diagnosis) were extracted from the
electronic health records. We use standard medical concept groupers to convert the available
ICD-9 or ICD-10 codes of diagnosis to Clinical Classification Software (CCS level 3) [21]. We also
group the normalized drug names based on unique therapeutic sub-classes using the Anatomical
Therapeutic Chemical (ATC) Classification System. Static information of patients includes their
gender, age, race, smoking status, alcohol status and BMI.
Centers for Medicare and Medicaid (CMS):2 The next data set is CMS 2008-2010 Data
Entrepreneurs’ Synthetic Public Use File (DE-SynPUF). The goal of CMS data set is to provide a
set of realistic data by protecting the privacy of Medicare beneficiaries by using 5% of real data to
synthetically construct the whole dataset. We extract the ICD-9 diagnosis codes and convert them
to CCS diagnostic categories as in the case of Sutter dataset.
4.2 Evaluation metrics:
• RMSE: Accuracy is evaluated as the Root Mean Square Error (RMSE) which is a standard
measure used in coupled matrix-tensor factorization literature [22, 23]. Given input collection
of matrices Xk ∈ RIk×J ,∀k = 1, ...,K and static input matrix A ∈ RK×P , we define
RMSE =
√√√√√√
K∑
k=1
Ik∑
i=1
J∑
j=1
(Xk(i, j)− Xˆk(i, j))2 + λ2
K∑
k=1
P∑
j=1
(A(i, j)− Aˆ(i, j))2∑K
k=1(Ik × J) +K × P
(11)
Xk(i, j) denotes the (i, j) element of input matrixXk and Xˆk(i, j) its approximation through
a model’s factors (the (i, j) element of the product UkSkV T in the case of TASTE). Similarly,
A(i, j) is the (i, j) element of input matrix A and Aˆ(i, j) is its approximation (in TASTE, this
is the (i, j) element of WF T ).
• Cross-Product Invariance (CPI): We use CPI to assess the solution’s uniqueness, since
this is the core constraint promoting it [11]. In particular we check whether UTk Uk is close to
constant (HTH) ∀k ∈ {1, . . . ,K}). The cross-product invariance measure is defined as:
CPI = 1−
∑K
k=1 ||UTk Uk −HTH||2F∑K
k=1 ||HTH||2F
.
2https://www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/SynPUFs/
DE_Syn_PUF.html
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The range of cross-product invariance is between [−∞, 1], with values close to 1 indicating
unique solutions (UTk Uk is close to constant).
• Area Under the ROC Curve (AUC): Examines classification model’s performance when
the data is imbalance by comparing the actual and estimated labels. We use AUC on the test
set to evaluate predictive model performance.
4.3 Q1. TASTE is fast, accurate and preserves uniqueness-promoting con-
straints
4.3.1 Baseline Approaches:
In this section, we compare TASTE with methods that incorporate non-negativity constraint on all
factor matrices. Note that SPARTan [8] and COPA [9] are not able to incorporate non-negativity
constraint on factor matrices {Uk}.
• Cohen+ [24]: Cohen et al. proposed a PARAFAC2 framework which imposes non-negativity
constraints on all factor matrices based on non-negative least squares algorithm [17]. We
modified this method to handle the situation where static matrixA is coupled with PARAFAC2
input based on Figure 1. To do so, we add λ2 ||A−WF T ||2F to their objective function and
updated both factor matrices W and F in an Alternating Least Squares manner, similar to
how the rest of the factors are updated in [24].
• COPA+: One simple and fast way to enforce non-negativity constraint on factor matrix
Uk is to compute Uk as: Uk := max(0,QkH), where max() is taken element-wise to ensure
non-negative results. Therefore, we modify the implementation in [9] to handle both the
PARAFAC2 input and the static matrix A and then apply the simple heuristic to make {Uk}
non-negative. We will show in the experimental results section that how this heuristic method
no longer guarantees unique solutions (violates model constraints).
We provide the details about tuning hyperparameters in the supplementary material section.
4.3.2 Results:
Apart from purely evaluating the RMSE and the computational time achieved, we assess to what
extent the cross-product invariance constraint is satisfied [11]. Therefore, in Figure 2 we present
the average and standard deviation of RMSE, CPI, and the computational time for the approaches
under comparison for Sutter and CMS data sets for four different target ranks (R ∈ {5, 10, 20, 40}).
In Figures 2a, 2b, we compare the RMSE for all three methods. We remark that all methods
achieve comparable RMSE values for two different data sets. On the other hand, Figures 2c, 2d
show the cross-product invariance (CPI) for Sutter and CMS respectively. COPA+ achieves poor
values of CPI for both data sets. This indicates that the output factors violate model constraints
and would not satisfy uniqueness properties [11]. Also TASTE outperforms Cohen significantly on
CPI in Figures 2c and 2d. Finally, Figures 2e, 2f show the running time comparison for all three
methods on where TASTE is up to 4.5× and 2× faster than Cohen on Sutter and CMS data sets.
Therefore, our approach is the only one that achieves a fast and accurate solution (in terms of
RMSE) and preserves model uniqueness (in terms of CPI).
4.4 Q2. TASTE is scalable
Apart from assessing the time needed for increasing values of target rank (i.e., number of phenotypes),
we evaluate the approaches by comparison in terms of time needed for increasing load of input
patients. Each method runs for 5 times and the convergence threshold is set to 1e−4 for all of them.
Figure 3 compares the average and standard deviation of total running time for 125K, 250K, 500K,
and 1 Million patients for R = 40. TASTE is up to 14× faster than Cohen’s baseline for R = 40.
While COPA+ is a fast approach, this baseline suffers from not satisfying model constraints which
promote uniqueness.
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Figure 2: The average and standard deviation of RMSE (lower is better), CPI (higher is better),
and total running time (in seconds) (lower is better) for different approaches and for different target
ranks (R = {5, 10, 20, 40}) related to 5 different random initialization for Sutter and CMS data sets.
4.5 Q3. Static features in TASTE improve predictive power
We measure the performance of TASTE indirectly on the performance of classification. So we
predict whether a patient will be diagnosed with heart failure (HF) or not. Our objective is to
assess whether static features in the way handled by TASTE boost predictive performance by using
personalized phenotype scores for all patients (W ) as features.
4.5.1 Cohort Construction:
After applying the preprocessing steps (i.e. removing sparse features and eliminating patients with
less than 5 clinical visits), we create a data set with 35113 patients where 3244 of them are cases
and 31869 related to controls (9.2 % are cases). For case patients, we know the date that they are
diagnosed with heart failure (HF dx). Control patients also have the same index dates as their
corresponding cases. We extract 145 medications and 178 diagnosis codes from a 2-year observation
window and set prediction window length to 6 months. Figure 5 in the supplementary material
section depicts the observation and prediction windows in more detail.
4.5.2 Baselines:
We assess the performance of TASTE with 6 different baselines.
• RNN-regularized CNTF: CNTF [4] feeds the temporal phenotype evolution matrices
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Figure 3: The average and standard deviation of running time (in seconds) for R = 40 and for
5 random initialization by varying number of patients from 125K to 1 million for CMS data set.
TASTE is upto 14× faster than Cohen.
({Uk}) into an LSTM model for HF prediction. This baseline only uses temporal medical
features.
• RNN Baseline: We use the GRU model for HF prediction implemented in [25]. The one-hot
vector format is used to represent all dynamic and static features for different clinical visits.
• Logistic regression with raw dynamic: We create a binary matrix where the rows are
the number of patients and columns are the total number of medical features (323). Row k of
this matrix is created by aggregating over all clinical visits of matrix Xk.
• Logistic regression with raw static+dynamic: Same as the previous approach, we create
a binary matrix where the rows are number of patients and columns are the total number of
temporal and static features (345) by appending matrix A to raw dynamic baseline matrix.
• COPA Personalized Score Matrix: We use the implementation of pure PARAFAC2 from
[9] which learn the low-rank representation of phenotypes (Vcopa) from training set and then
projecting all the new patients onto the learned phenotypic low-rank space.
• COPA (+static) Personalized Score Matrix: This is same as previous baseline, however,
we incorporate the static features into PARAFAC2 matrix by repeating the value of static
features of a particular patient for all encounter visits.
20 40 60 80 100
R (Target Rank)
0.62
0.64
0.66
0.68
0.70
0.72
0.74
0.76
AU
C
RNN Baseline (345 features)
LR with raw dynamic+static (345 features)
LR with raw dynamic (323 features)
TASTE
COPA
COPA(+static)
CNTF
Figure 4: The average of AUC score for varying number of phenotypes (R) for TASTE and 3 other
tensor baselines on the test set. The AUC score for a baseline with raw dynamic features (323) is
0.7426, for the raw dynamic+static baseline (345) is 0.7498 and for RNN baseline is 0.7547.
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Results: Figure 4 shows the average of AUC for all baselines and TASTE. For COPA, COPA(+static),
CNTF and TASTE we report the AUC score for different values of R ({5,10,20,40,60,80,100}). TASTE
improves the AUC score over a simple non-negative PARAFAC2 model (COPA and COPA(+static))
and CNTF which suggests: 1) incorporating static features with dynamic ones will increase the
predictive power (comparison of TASTE with COPA and CNTF). 2) incorporating static features
in the way we do in TASTE improves predictive power (comparison of TASTE and COPA(+static)).
TASTE with R=80 (AUC=0.7554) performs slightly better than the RNN model. Training details
are provided in the supplementary material section.
4.6 Q4. Heart Failure Phenotype Discovery
Heart failure (HF) is a complex, heterogeneous disease and is the leading cause of hospitalization
in people older than 65 3. However, there are no well-defined phenotypes other than the simple
categorization of ejection fraction of the heart (i.e., preserved or reduced ejection fraction). With
the comprehensive collection of available longitudinal EHR data, now we have the opportunity to
computationally tackle the challenge of phenotyping HF patients.
4.6.1 Cohort Construction:
We select the patients diagnosed with HF from the EHRs in Sutter dataset. We extract 145
medications and 178 diagnosis codes from a 2-year observation window which ends 6 months before
the heart failure diagnosis date (HFdx)4. The total number of patients (K) is 3,244 (the HF case
patients of Sutter dataset).
4.6.2 Findings of HF Phenotypes
TASTE extracted 5 phenotypes which are all confirmed and annotated by an expert cardiologist 5.
The clinical description of all phenotype are provided by the cardiologist:
P1. Atrial Fibrillation (AF): This phenotype represents patients with irregular heartbeat and
AF predisposes to HF. Medications are related to managing AF and preventing strokes. This
phenotype is usually more prevalent in male and old patients (i.e. 80 years or older).
P2. Hypertensive Heart Failure: This is a classic and dominant heart failure phenotype,
representing a subgroup of patients with long history of hypertension, and cardiac performance
declines over time. Anti-hypertensive medications are spelled out as to indicate the treatment
to hypertension.
P3. Obese Induced Heart Failure: This phenotype is featured by severe obesity (BMI>35)
and obesity induced orthopedic condition.
P4. Cardiometablic Driving Heart Failure: This phenotype is featured by diabetes and
cardiometabolic conditions (i.e. hyperlipidemia, hypertension). Diabetes is a well known risk
factor for cardiovascular complications (i.e. stroke, myocardial infaction, etc.), and increases
the risk for heart failure.
P5. Coronary Heart Disease Phenotype: This phenotype is associated with a greater deteri-
oration of left ventricle function and a worse prognosis. This phenotype is also more prevalent
in male and white population.
More detail about all phenotypes is provided in the supplementary material section.
5 Conclusions
TASTE jointly models temporal and static information from electronic health records to extract
clinically meaningful phenotypes. We demonstrate the computational efficiency of our model on
extensive experiments that showcase its ability to preserve important properties underpinning
3https://www.webmd.com/heart-disease/guide/diseases-cardiovascular\#1-4
4Figure 5 in the supplementary material section presents the observation window in more detail.
5More detail about the strategy for finding the optimal number of phenotypes is provided in the supplementary
material section.
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the model’s uniqueness, while maintaining interpretability. TASTE not only identifies clinically
meaningful heart failure phenotypes validated by a cardiologist but the phenotypes also retain
predictive power for predicting heart failure.
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7 Supplementary Material
7.1 Non-Negativity constrained Least Squares (NNLS)
NNLS problem has the following form:
minimize
C
∥∥∥BCT −A∥∥∥2
F
subject to C ≥ 0
(12)
Here, A ∈ RM×N , B ∈ RM×R and C ∈ RN×R where R  min(M,N). NNLS is a convex
problem and the optimal solution of 12 can be easily found. In this paper, we use the block principal
pivoting method [19] to solve NNLS problems. Authors showed block principal pivoting method
has the state-of-the-art performance.
7.2 More details on TASTE framework
7.2.1 Updating factor matrix Qk
We can rewrite objective function 2 with respect to Qk based on trace properties [26] as:
minimize
Qk
µk
2
Trace(UTk Uk)︸ ︷︷ ︸
constant
−µkTrace(UTk QkH)
+
µk
2
Trace(HTQTkQkH)︸ ︷︷ ︸
constant
subject to QTkQk = I
(13)
After removing the constant terms and applying Trace(ABC) = Trace(CAB), we have:
minimize
Qk
µk
∥∥∥UkHT −Qk∥∥∥2
F
subject to QTkQk = I
(14)
7.2.2 Updating factor matrix H
Qk ∈ RIk×R is a rectangular orthogonal matrix (QTkQk = I ∈ RR×R). We also introduce
Q˜k ∈ RIk×Ik−R where Q˜k
T
Q˜k = I ∈ RIk−R×Ik−R and Q˜k
T
Qk = 0. Now [Qk Q˜k] is a square
orthogonal matrix as follows:[
QTk
Q˜k
T
] [
Qk Q˜k
]
=
[
QTkQk Q
T
k Q˜k
Q˜k
T
Qk Q˜k
T
Q˜k
]
=
[
IR×R 0
0 I(Ik−R)×(Ik−R)
]
= IIk×Ik
(15)
Now we multiply [Qk Q˜k] with equation 16 as follow:
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K∑
k=1
µk
2
‖QkH −Uk‖2F
=
K∑
k=1
µk
2
∥∥∥[Qk Q˜k]T(QkH −Uk)∥∥∥2
F
=
K∑
k=1
µk
2
∥∥∥∥∥
[
QTk
Q˜k
T
](
QkH −Uk
)∥∥∥∥∥
2
F
=
K∑
k=1
µk
2
∥∥∥∥∥
[
QTkQk
Q˜k
T
Qk
]
H −
[
QTkUk
Q˜k
T
Uk
]∥∥∥∥∥
2
F
=
K∑
k=1
(µk
2
∥∥∥H −QTkUk∥∥∥2
F
+
constant︷ ︸︸ ︷∥∥∥Q˜kTUk∥∥∥2
F
)
(16)
where
∑K
k=1
∥∥∥Q˜kTUk∥∥∥2
F
is a constant and independent of the parameter under minimization.
Therefore, the value ofH that minimizes
∑K
k=1
µk
2 ‖QkH −Uk‖2F also minimizes
∑K
k=1
µk
2
∥∥H −QTkUk∥∥2F
7.3 Implementation details
TASTE is implemented in MATLAB. To enable reproducibility of our work, we attached a zip file
containing TASTE code. All the approaches (including the baselines) are evaluated on MatlabR2017b.
We utilize the capabilities of Parallel Computing Toolbox of Matlab by activating parallel pool for
all methods. For Sutter and CMS dataset, we used 12 workers. For the prediction task, we use
the implementation of regularized logistic regression from Scikit-learn machine learning library of
python 3.6.
7.4 More details on Q1. TASTE is fast, accurate and preserves uniqueness-
promoting constraints
7.4.1 Setting hyper-parameters:
We perform a grid search for λ ∈ {0.01, 0.1, 1} and µ1 = · · · = µK = µ ∈ {0.01, 0.1, 1} for TASTE
and Cohen+ for different target ranks (R = {5, 10, 20, 40}) and we run each method with specific
parameter for 5 random initialization and pick the best values of λ and µ based on the lowest
average RMSE value. For COPA+, we just search for the best value of λ ∈ {0.1, 1, 10} since it does
not require µ parameter.
7.5 More details on Q3. Static features in TASTE improve predictive
power
7.5.1 Training Details:
We train a Lasso Logistic Regression for all the baselines under comparison. We divide the
patient records into training (75%), validation (10%), and test sets (15%) and use them to
evaluate all baselines. Lasso Logistic Regression has regularization parameter (C = [1e− 2, 1e−
1, 1, 10, 100, 1000, 10000]). For all 6 baselines, we just need to tune parameter C. However, for
TASTE we need to perform a 3-D grid search over λ ∈ {0.01, 0.1, 1} and µ1 = µ2 = · · · = µK =
µ =∈ {0.01, 0.1, 1} and C. We first train TASTE on training set and learn the phenotype low-rank
representation (V , F ) and then train Lasso Logistic Regression classifier based on patient low-rank
representation (Wtrain) and corresponding labels. Then we project the patients in validation set
on phenotype low-rank representation and learn their personalized phenotype scores Wval. Next,
we feed Wval into a Lasso Logistic Regression and calculate the AUC score. Finally, we pick the
best parameters based on the highest AUC score on validation set and report the AUC on test data.
The training phase for COPA, COPA(+static) and CNTF is same as TASTE.
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Table 3: TASTE extracted 5 phenotypes from the HF dataset. Red indicates the static features; Dx_ indicates
diagnoses; Rx_ indicates medication; The phenotype names are provided by the cardiologist.
P1. Atrial Fibrillation (AF) Weight
Dx_Cardiac dysrhythmias [106.] 1
Rx_Coumarin Anticoagulants 0.79597
Dx_Heart valve disorders [96.] 0.57526
Dx_Coronary atherosclerosis and other heart disease [101.] 0.465406
Rx_Beta Blockers Cardio-Selective 0.348005
Dx_Conduction disorders [105.] 0.246467
Static_white 0.270443
Static_age_greater_80 0.245424
Static_Non_Hispanic 0.245373
Static_male 0.200464
Static_Alchohol_yes 0.197431
Static_Smk_Quit 0.167838
P2. Hypertensive Heart Failure: Weight
Dx_Essential hypertension [98.] 0.705933
Rx_Calcium Channel Blockers 0.684211
Rx_ACE Inhibitors 0.578426
Rx_Beta Blockers Cardio-Selective 0.564413
Rx_Angiotensin II Receptor Antagonists 0.250883
Dx_Chronic kidney disease [158.] 0.14528
Rx_Thiazides and Thiazide-Like Diuretics 0.134521
Static_Non_Hispanic 0.536399
Static_female 0.390343
Static_Smk_NO 0.363068
Static_Alchohol_No 0.360158
Static_white 0.345942
Static_Alchohol_yes 0.264664
Static_age_between_70_79 0.26237
Static_Severely_obese 0.252981
P3. Obese Induced Heart Failure: Weight
Dx_Other back problems 0.438879
Rx_Opioid Combinations 0.414518
Dx_Other connective tissue disease [211.] 0.304155
Dx_Other non-traumatic joint disorders [204.] 0.269159
Dx_Osteoarthritis [203.] 0.190075
Rx_Opioid Agonists 0.185262
Dx_Intervertebral disc disorders 0.156421
Rx_Benzodiazepines 0.150865
Static_female 0.548758
Static_Non_Hispanic 0.52183
Static_white 0.474545
Static_Alchohol_No 0.404191
Static_Smk_Quit 0.273576
Static_Severely_obese 0.226485
Static_age_between_70_79 0.180683
Static_age_between_60_69 0.180006
P4. Cardiometablic Driving Heart Failure: Weight
Dx_Diabetes mellitus without complication [49.] 0.712628
Dx_Disorders of lipid metabolism [53.] 0.507946
Rx_Biguanides 0.48821
Dx_Immunizations and screening for infectious disease [10.] 0.358349
Rx_Diagnostic Tests 0.353441
Static_Alchohol_No 0.247165
Static_Non_Hispanic 0.190547
Static_Smk_NO 0.184782
Static_male 0.164795
Static_white 0.15693
Static_age_between_60_69 0.131118
P5. Coronary Heart Disease Phenotype: Weight
Dx_Disorders of lipid metabolism [53.] 0.984987
Rx_HMG CoA Reductase Inhibitors 0.442637
Dx_Coronary atherosclerosis and other heart disease [101.] 0.265414
Dx_Diabetes with renal manifestations 0.229549
Dx_Chronic kidney disease [158.] 0.203386
Dx_Other thyroid disorders 0.101615
Static_Non_Hispanic 1
Static_white 0.998604
Static_male 0.957132
Static_Smk_Quit 0.773904
Static_Alchohol_yes 0.604641
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7.6 More details on Q4. Heart Failure Phenotype Discovery
Figure 5: The arrow represents the encounter visits of a patient. We extract diagnosis and
medications from a 2-year observation window by setting prediction window length to 6 months.
7.6.1 Hyper-parameter search:
The optimal number of phenotypes (R), λ, and µ need to be tuned. So, We perform a 3-D grid search
for R = {3, 4, 5, ..., 20}, λ ∈ {0.01, 0.1, 1} and µ1 = µ2 = · · · = µK = µ =∈ {0.01, 0.1, 1} based
on the stability-driven metric provided in [27]. Stability-driven metric calculates the dissimilarity
between a pair of factor matrices from two different initialization (V ,V ’) using the cross-correlation
matrix (C) as follows: diss(V ,V ′) = 12R
(
2R−∑Ri=1 max1≤j≤RCij−∑Rj=1 max1≤i≤RCij) where diss(V ,V ’)
denotes the dissimilarity between factor matrices V ,V ’. Also cross-correlation matrix (C ∈ RR×R)
computes the cosine similarity between all columns of V ,V ’. We run TASTE model for 10 different
random initialization and compute the average dissimilarity for each value of R, λ, and µ. Figure
6 shows the best value of stability-driven metric for different values for R. The best solution
corresponding to R = 5, λ = 0.1, µ = 0.1 were chosen as the one achieving the lowest average
dissimilarity. Then, for fixed R = 5, λ = 0.1, µ = 0.1 we present the phenotypes of the model
achieving the lowest RMSE among the 10 different runs.
Figure 6: Stability-driven metric for different values of phenotypes(R = {3, 4, ..., 20}). The optimal value of
phenotypes corresponds to the minimum value of stability-driven metric (R = 5).
7.6.2 Phenotype definition:
We provide the details of all 5 phenotypes discovered by TASTE in Table 3.
7.6.3 Pure PARAFAC2 cannot handle static feature integration.
In this Section, we illustrate the fact that a naive way of incorporating static feature information
into a simpler PARAFAC2-based framework [9] would result in poor, less interpretable phenotypes.
We incorporate the static features into PARAFAC2 input by repeating the value of static features
on all clinical visits of the patients same as what we did for COPA(+static). For instance, if the
male feature of patient k has value 1, we repeat the value 1 for all the clinical visits of that patient.
Then we compare the phenotype definitions discovered by TASTE (matrices V , F ) and by COPA
(matrix V ). Table 4 contains two sample phenotypes discovered by this baseline, using the same
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Table 4: Two sample phenotypes discovered by COPA(+static) baseline by naively integrating
static features into a simpler PARAFAC2-based model [9] .
Phenotype 1 weight
Static_Alcohol_yes 0.3860
Static_White 0.2160
Static_Non_Hispanic 0.2064
Static_Smk_Quit 0.1743
Static_male 0.1508
Static_moderately_obese 0.1025
Phenotype 2 weight
Static_age_between_70_79 1
Static_Non_Hispanic 0.8233
Static_White 0.7502
Static_Alcohol_No 0.6905
Static_moderately_obese 0.2098
Static_male 0.2026
Static_Smk_No 0.1614
truncation threshold that we use throughout this work (we only consider features with values
greater than 0.1). We observe that the static features introduce a significant amount of bias into the
resulting phenotypes: the phenotype definitions are essentially dominated by static features, while
the values of weights corresponding to dynamic features are closer to 0. This suggests that pure
PARAFAC2-based models such as the work in [9] are unable to produce meaningful phenotypes that
handle both static and dynamic features. Such a conclusion extends to other PARAFAC2-based
work which does not explicitly model side information [11, 8, 24].
7.7 Recovery of true factor matrices
In this section, we assess to what extent the original factor matrices can be recovered through
synthetic data experiments 6. We demonstrate that: a) TASTE recovers the true latent factors more
accurately than baselines for noisy data; and b) the baseline (COPA+) which does not preserve a
high CPI measure (which is known to be theoretically linked to uniqueness [11] 7) fails to match
TASTE in terms of latent factor recovery, despite achieving similar RMSE.
7.7.1 Evaluation Metric:
Similarity between two factor matrices: We define the cosine similarity between two vectors
xi, yj as Cij =
xTi yj
||xi||||yj || . Then the similarity between two factor matrices X ∈ RI×R, Y ∈ RI×R
can be computed as (similar to [11]):
Sim(X,Y ) =
R∑
i=1
max
1≤j≤R
Cij
R
The range of Sim is between [0,1] and the values near 1 indicate higher similarity.
7.7.2 Synthetic Data Construction:
We construct the ground-truth factor matrices H˜ ∈ RR×R, V˜ ∈ RJ×R, W˜ ∈ RK×R, F˜ ∈ RP×R
by drawing a number uniformly at random between (0,1) to each element of each matrix. For
each factor matrix Q˜k, we create a binary non-negative matrix such that Q˜Tk Q˜k = I and then
compute U˜k=Q˜kH˜. After constructing all factor matrices, we compute the input based on
Xk = U˜kdiag(W˜ (k, :))V˜
T and A = W˜ F˜ T . We set K = 100, J = 30, P = 20, Ik = 100, and
R = 4. We then add Gaussian normal noise to varying percentages of randomly-drawn elements
({5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%}) of Xk,∀k = 1, . . . ,K and A input matrices.
6The reason that we are working with synthetic data here is that we do not know the original factor matrices in
real data sets.
7A discussion on uniqueness can be found in Background and & Related Work Section.
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Figure 7: Figure 7a provides total average similarity between the estimated and the true factor
matrices for different noise levels ({5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%}) on synthetic data.
Figure 7b provides the CPI of three methods for different levels of noise for a synthetic data with
K=100, J=30, P=20, Ik = 100, R=4. All points in the figures is computed as an average of 5
random initialization. All three algorithms achieve similar values for RMSE.
7.7.3 Results:
For all approaches under comparison, all three methods achieve same value for RMSE, therefore,
we skip ploting RMSE vs different noise levels. We assess the similarity measure between each
ground truth latent factor and its corresponding estimated one (e.g., Sim(V˜ ,V )), and consider
the average Sim(·, ·) measure across all output factors as shown in Figure 7a. We also measure
CPI and provide the results in 7b for different levels of noise . We observe that despite achieving
comparable RMSE, COPA+ scores the lowest on the similarity between the true and the estimated
factors. On the other hand, TASTE achieves the highest amount of recovery, in accordance to the
fact that it achieves the highest CPI among all approaches. Overall, we demonstrate how promoting
uniqueness (by enforcing the CPI measure to be preserved [11]) leads to more accurate parameter
recovery, as suggested by prior work [11, 28].
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